BGIM
KERX

Brandywine Global Investment Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Brandywine Global Investment Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-164,259
Closed -$559K – 936
2018
Q3 		$559K Buy
164,259
+275
+0.2% +$991 ﹤0.01% 587
2018
Q2 		$617K Sell
163,984
-4,240
-3% -$20.6K ﹤0.01% 603
2018
Q1 		$689K Buy
+168,224
New +$783K ﹤0.01% 597
2016
Q3 		– Sell
-335,672
Closed -$2.22M – 1014
2016
Q2 		$2.22M Sell
335,672
-186,523
-36% -$1.04M 0.02% 544
2016
Q1 		$2.44M Buy
522,195
+31,775
+6% +$127K 0.02% 520
2015
Q4 		$2.48M Buy
490,420
+472,740
+2,674% +$2.25M 0.02% 532
2015
Q3 		$63K Sell
17,680
-2,798,154
-99% -$18.7M ﹤0.01% 833
2015
Q2 		$28.1M Buy
2,815,834
+894,435
+47% +$9.59M 0.18% 110
2015
Q1 		$24.5M Buy
+1,921,399
New +$24.7M 0.16% 131

Brandywine Global Investment Management's KERX Position: Q4 2018 in Review

Brandywine Global Investment Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 164,259 shares — an estimated $559K sold.

Brandywine Global Investment Management first reported a position in KERX in Q1 2015 and held it in 9 quarters. The position peaked at $28.1M in Q2 2015. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • Brandywine Global Investment Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Brandywine Global Investment Management sold 164,259 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $559K.
  • Brandywine Global Investment Management first reported a position in Keryx Biopharmaceuticals Inc in Q1 2015 and held it in 9 quarters.
  • Brandywine Global Investment Management's Keryx Biopharmaceuticals Inc position peaked at $28.1M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Brandywine Global Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.